Ventyx Biosciences Inc (NASDAQ: VTYX) on Monday, plunged -11.03% from the previous trading day, before settling in for the closing price of $0.94. Within the past 52 weeks, VTYX’s price has moved between $0.90 and $5.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -2.09%. With a float of $62.50 million, this company’s outstanding shares have now reached $71.13 million.
The extent of productivity of a business whose workforce counts for 82 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 12.13%, while institutional ownership is 78.63%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.01% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 17.97 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.99, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
The latest stats from [Ventyx Biosciences Inc, VTYX] show that its last 5-days average volume of 1.76 million was superior to 1.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 7.33%. Additionally, its Average True Range was 0.10.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 2.04%, which indicates a significant decrease from 8.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.16% in the past 14 days, which was lower than the 88.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5093, while its 200-day Moving Average is $2.0852. Now, the first resistance to watch is $0.9401. This is followed by the second major resistance level at $1.0440. The third major resistance level sits at $1.1226. If the price goes on to break the first support level at $0.7576, it is likely to go to the next support level at $0.6790. The third support level lies at $0.5751 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 59.47 million based on 71,130K outstanding shares. Right now, sales total 0 K and income totals -135,120 K. The company made 0 K in profit during its latest quarter, and -29,350 K in sales during its previous quarter.
